Sector revisions Merck & Co., Inc.

Equities

Market Closed - Nyse Other stock markets 04:00:57 21/05/2026 HKT			After hours 06:18:54
113.00 ^USD	-1.09%		113.38	+0.33%

05-21	National Advertising Review Board refers Merck animal health to FTC & FDA for Bravecto Quantum dosing claims	RE
05-20	Pharma sector doubles down on AI amid hopes of slashing costs, timelines	RE

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	MERCK & CO., INC.							27
	ELI LILLY AND COMPANY							29
	JOHNSON & JOHNSON							24
	ABBVIE INC.							29
	ROCHE HOLDING AG							17
	ASTRAZENECA PLC							21
	NOVARTIS AG							21
	NOVO NORDISK A/S							23
	AMGEN INC.							30
	GILEAD SCIENCES, INC.							28
	PFIZER INC.							27
	BRISTOL-MYERS SQUIBB COMPANY							25
	VERTEX PHARMACEUTICALS INCORPORATED							28
	SANOFI							23
	GSK PLC							20
	CHUGAI PHARMACEUTICAL CO., LTD.							15
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							15
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							17
	BAYER AG							19
	HALEON PLC							17
	Average							23
	Weighted average by Cap.							25